Berlin-Buch at the BIO INTERNATIONAL CONVENTION
2016-06-01 / The BBB Management GmbH will represent the Health Location Berlin-Buch in the German Pavilion at the most important global event for the biotechnology industry, the BIO International Convention. The BIO will take place June 6-9, 2016 in San Francisco, USA. Together with Berlin Partner and ZukunftsAgentur Brandenburg GmbH, BBB will present the biotechnology and the life sciences capabilities of the German capital region.
Photo: Peter Himsel
Berlin-Buch is the location of one of the largest biotechnology parks in Germany, with 31.000 square meters of scalable lab and office space for start-ups and maturing companies. Situated to the northeast of the city, the Berlin-Buch Campus is currently home to 65 companies, 47 of which are biotech companies; the rest provides support services.
Beside the BiotechPark the Max Delbrück Center for Molecular Medicine (MDC), the Leibniz-Institute for Molecular Pharmacology as well as clinical groups from the Charité University Medicine Berlin and the Berlin Institute of Health are part of the Campus community. The Campus gives access to high-end technology platforms, state of the art infrastructure, interdisciplinary communication, projects and expertise in a wide range of items, especially in translational research.
The science and health campus in Buch is one of Berlin’s outstanding future-oriented locations. With its clear focus on the life sciences, biotechnology and medicine, Buch has great potential for growth and innovation. Buch offers more than 6,000 jobs in the health sector and is developing into an exemplary green health city, in which research and production, healthcare and everyday life are linked in a unique way.
Dr. Christina Quensel, CEO
BBB Management GmbH Campus Berlin-Buch
Tel.: +49 30 9489-2511
Fax: +49 30 6392-2235